Bayer AG

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, BMYMP has a market cap of 2T. Regarding current trading prices, BAYRY is priced at $13.28, while BMYMP trades at $1,002.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas BMYMP's P/E ratio is 4457.47. In terms of profitability, BAYRY's ROE is -0.01%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, BAYRY is more volatile compared to BMYMP. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check BMYMP's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, RHHBF has a market cap of 385.2B. Regarding current trading prices, BAYRY is priced at $13.28, while RHHBF trades at $483.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas RHHBF's P/E ratio is 23.21. In terms of profitability, BAYRY's ROE is -0.01%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, BAYRY is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check RHHBF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, RHHBY has a market cap of 382B. Regarding current trading prices, BAYRY is priced at $13.28, while RHHBY trades at $59.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas RHHBY's P/E ratio is 22.81. In terms of profitability, BAYRY's ROE is -0.01%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, BAYRY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check RHHBY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, RHHVF has a market cap of 366.2B. Regarding current trading prices, BAYRY is priced at $13.28, while RHHVF trades at $477.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas RHHVF's P/E ratio is 22.06. In terms of profitability, BAYRY's ROE is -0.01%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, BAYRY is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check RHHVF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, AZNCF has a market cap of 323.4B. Regarding current trading prices, BAYRY is priced at $13.28, while AZNCF trades at $208.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas AZNCF's P/E ratio is 34.60. In terms of profitability, BAYRY's ROE is -0.01%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, BAYRY is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check AZNCF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, NVSEF has a market cap of 317.4B. Regarding current trading prices, BAYRY is priced at $13.28, while NVSEF trades at $166.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas NVSEF's P/E ratio is 23.23. In terms of profitability, BAYRY's ROE is -0.01%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, BAYRY is less volatile compared to NVSEF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check NVSEF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, GLAXF has a market cap of 125.9B. Regarding current trading prices, BAYRY is priced at $13.28, while GLAXF trades at $31.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas GLAXF's P/E ratio is 16.51. In terms of profitability, BAYRY's ROE is -0.01%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, BAYRY is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check GLAXF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, SNYNF has a market cap of 115B. Regarding current trading prices, BAYRY is priced at $13.28, while SNYNF trades at $93.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas SNYNF's P/E ratio is 19.84. In terms of profitability, BAYRY's ROE is -0.01%, compared to SNYNF's ROE of +0.15%. Regarding short-term risk, BAYRY is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check SNYNF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, CHGCY has a market cap of 105.8B. Regarding current trading prices, BAYRY is priced at $13.28, while CHGCY trades at $30.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas CHGCY's P/E ratio is 37.39. In terms of profitability, BAYRY's ROE is -0.01%, compared to CHGCY's ROE of +0.23%. Regarding short-term risk, BAYRY is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check CHGCY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, CHGCF has a market cap of 102B. Regarding current trading prices, BAYRY is priced at $13.28, while CHGCF trades at $61.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas CHGCF's P/E ratio is 36.05. In terms of profitability, BAYRY's ROE is -0.01%, compared to CHGCF's ROE of +0.22%. Regarding short-term risk, BAYRY is more volatile compared to CHGCF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check CHGCF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, OTSKY has a market cap of 37.4B. Regarding current trading prices, BAYRY is priced at $13.28, while OTSKY trades at $33.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas OTSKY's P/E ratio is 15.30. In terms of profitability, BAYRY's ROE is -0.01%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, BAYRY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check OTSKY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, OTSKF has a market cap of 37.1B. Regarding current trading prices, BAYRY is priced at $13.28, while OTSKF trades at $70.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas OTSKF's P/E ratio is 14.50. In terms of profitability, BAYRY's ROE is -0.01%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, BAYRY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check OTSKF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, DSNKY has a market cap of 35.3B. Regarding current trading prices, BAYRY is priced at $13.28, while DSNKY trades at $18.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas DSNKY's P/E ratio is 19.27. In terms of profitability, BAYRY's ROE is -0.01%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, BAYRY is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check DSNKY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, DSKYF has a market cap of 34.9B. Regarding current trading prices, BAYRY is priced at $13.28, while DSKYF trades at $18.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas DSKYF's P/E ratio is 19.21. In terms of profitability, BAYRY's ROE is -0.01%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, BAYRY is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check DSKYF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, ALPMF has a market cap of 29.4B. Regarding current trading prices, BAYRY is priced at $13.28, while ALPMF trades at $15.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas ALPMF's P/E ratio is 37.28. In terms of profitability, BAYRY's ROE is -0.01%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, BAYRY is less volatile compared to ALPMF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check ALPMF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, ALPMY has a market cap of 28.5B. Regarding current trading prices, BAYRY is priced at $13.28, while ALPMY trades at $16.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas ALPMY's P/E ratio is 34.63. In terms of profitability, BAYRY's ROE is -0.01%, compared to ALPMY's ROE of +0.20%. Regarding short-term risk, BAYRY is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check ALPMY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, ORINY has a market cap of 22.8B. Regarding current trading prices, BAYRY is priced at $13.28, while ORINY trades at $40.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas ORINY's P/E ratio is 19.23. In terms of profitability, BAYRY's ROE is -0.01%, compared to ORINY's ROE of +0.47%. Regarding short-term risk, BAYRY is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check ORINY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, GIKLY has a market cap of 17B. Regarding current trading prices, BAYRY is priced at $13.28, while GIKLY trades at $6.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas GIKLY's P/E ratio is 20.16. In terms of profitability, BAYRY's ROE is -0.01%, compared to GIKLY's ROE of +0.07%. Regarding short-term risk, BAYRY is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check GIKLY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, CHJTF has a market cap of 15.9B. Regarding current trading prices, BAYRY is priced at $13.28, while CHJTF trades at $1.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas CHJTF's P/E ratio is 27.80. In terms of profitability, BAYRY's ROE is -0.01%, compared to CHJTF's ROE of +0.06%. Regarding short-term risk, BAYRY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check CHJTF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, CSPCY has a market cap of 14.9B. Regarding current trading prices, BAYRY is priced at $13.28, while CSPCY trades at $5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas CSPCY's P/E ratio is 27.11. In terms of profitability, BAYRY's ROE is -0.01%, compared to CSPCY's ROE of +0.06%. Regarding short-term risk, BAYRY is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check CSPCY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, ORINF has a market cap of 11.1B. Regarding current trading prices, BAYRY is priced at $13.28, while ORINF trades at $78.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas ORINF's P/E ratio is 25.30. In terms of profitability, BAYRY's ROE is -0.01%, compared to ORINF's ROE of +0.47%. Regarding short-term risk, BAYRY is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check ORINF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, RCDTF has a market cap of 10B. Regarding current trading prices, BAYRY is priced at $13.28, while RCDTF trades at $49.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas RCDTF's P/E ratio is 21.40. In terms of profitability, BAYRY's ROE is -0.01%, compared to RCDTF's ROE of +0.21%. Regarding short-term risk, BAYRY is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check RCDTF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, BAYRY is priced at $13.28, while GIFOF trades at $8.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas GIFOF's P/E ratio is 13.83. In terms of profitability, BAYRY's ROE is -0.01%, compared to GIFOF's ROE of +0.07%. Regarding short-term risk, BAYRY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check GIFOF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, KYKOF has a market cap of 8.2B. Regarding current trading prices, BAYRY is priced at $13.28, while KYKOF trades at $15.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas KYKOF's P/E ratio is 18.70. In terms of profitability, BAYRY's ROE is -0.01%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, BAYRY is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check KYKOF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, GIFLF has a market cap of 7.9B. Regarding current trading prices, BAYRY is priced at $13.28, while GIFLF trades at $11.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas GIFLF's P/E ratio is 18.22. In terms of profitability, BAYRY's ROE is -0.01%, compared to GIFLF's ROE of +0.07%. Regarding short-term risk, BAYRY is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check GIFLF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, OPHLY has a market cap of 7.8B. Regarding current trading prices, BAYRY is priced at $13.28, while OPHLY trades at $5.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas OPHLY's P/E ratio is 23.17. In terms of profitability, BAYRY's ROE is -0.01%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, BAYRY is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check OPHLY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, OPHLF has a market cap of 7.6B. Regarding current trading prices, BAYRY is priced at $13.28, while OPHLF trades at $16.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas OPHLF's P/E ratio is 22.89. In terms of profitability, BAYRY's ROE is -0.01%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, BAYRY is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check OPHLF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, BAYRY is priced at $13.28, while DPHAY trades at $98.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, BAYRY's ROE is -0.01%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, BAYRY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check DPHAY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, SNPHY has a market cap of 3.7B. Regarding current trading prices, BAYRY is priced at $13.28, while SNPHY trades at $11.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas SNPHY's P/E ratio is 18.82. In terms of profitability, BAYRY's ROE is -0.01%, compared to SNPHY's ROE of +0.11%. Regarding short-term risk, BAYRY is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check SNPHY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, PTKFF has a market cap of 3.2B. Regarding current trading prices, BAYRY is priced at $13.28, while PTKFF trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas PTKFF's P/E ratio is N/A. In terms of profitability, BAYRY's ROE is -0.01%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, BAYRY is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check PTKFF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, HAWPF has a market cap of 3.1B. Regarding current trading prices, BAYRY is priced at $13.28, while HAWPF trades at $14.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas HAWPF's P/E ratio is 15.74. In terms of profitability, BAYRY's ROE is -0.01%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, BAYRY is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check HAWPF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, SNPHF has a market cap of 3.1B. Regarding current trading prices, BAYRY is priced at $13.28, while SNPHF trades at $9.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas SNPHF's P/E ratio is 16.12. In terms of profitability, BAYRY's ROE is -0.01%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, BAYRY is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check SNPHF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, VRBCF has a market cap of 2.9B. Regarding current trading prices, BAYRY is priced at $13.28, while VRBCF trades at $346.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas VRBCF's P/E ratio is 17.04. In terms of profitability, BAYRY's ROE is -0.01%, compared to VRBCF's ROE of +0.13%. Regarding short-term risk, BAYRY is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check VRBCF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, HAWPY has a market cap of 2.7B. Regarding current trading prices, BAYRY is priced at $13.28, while HAWPY trades at $49.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas HAWPY's P/E ratio is 13.77. In terms of profitability, BAYRY's ROE is -0.01%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, BAYRY is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check HAWPY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, CMOPF has a market cap of 2.5B. Regarding current trading prices, BAYRY is priced at $13.28, while CMOPF trades at $159.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas CMOPF's P/E ratio is 37.36. In terms of profitability, BAYRY's ROE is -0.01%, compared to CMOPF's ROE of +0.12%. Regarding short-term risk, BAYRY is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check CMOPF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, LYPHF has a market cap of 1.5B. Regarding current trading prices, BAYRY is priced at $13.28, while LYPHF trades at $0.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas LYPHF's P/E ratio is 18.88. In terms of profitability, BAYRY's ROE is -0.01%, compared to LYPHF's ROE of +0.03%. Regarding short-term risk, BAYRY is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check LYPHF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, BAYRY is priced at $13.28, while TGRNF trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, BAYRY's ROE is -0.01%, compared to TGRNF's ROE of +0.06%. Regarding short-term risk, BAYRY is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check TGRNF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, BAYRY is priced at $13.28, while JCRRF trades at $4.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, BAYRY's ROE is -0.01%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, BAYRY is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check JCRRF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, MAYNF has a market cap of 150.7M. Regarding current trading prices, BAYRY is priced at $13.28, while MAYNF trades at $1.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas MAYNF's P/E ratio is -2.35. In terms of profitability, BAYRY's ROE is -0.01%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, BAYRY is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check MAYNF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, PTKFY has a market cap of 15.1M. Regarding current trading prices, BAYRY is priced at $13.28, while PTKFY trades at $13.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas PTKFY's P/E ratio is 14.61. In terms of profitability, BAYRY's ROE is -0.01%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, BAYRY is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check PTKFY's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, PSYGF has a market cap of 2.2M. Regarding current trading prices, BAYRY is priced at $13.28, while PSYGF trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas PSYGF's P/E ratio is -0.19. In terms of profitability, BAYRY's ROE is -0.01%, compared to PSYGF's ROE of +3.04%. Regarding short-term risk, BAYRY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for BAYRY.Check PSYGF's competition here

BAYRY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BAYRY stands at 50.2B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, BAYRY is priced at $13.28, while CRXTQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BAYRY currently has a P/E ratio of -213.00, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, BAYRY's ROE is -0.01%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, BAYRY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for BAYRY.Check CRXTQ's competition here